GlassScriptPhysician profile
Allison A Van Haastert
NPI 1801024021
$6,181.93
in general payments reported to CMS, 2019-2025
15 companies · $188 in 2025
The $188 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,004 · 2020: $607 · 2021: $3,015 · 2022: $168 · 2023: $163 · 2024: $36.94 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.92 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,611.14 | 2019-2021 | |
| Hologic Sales and Service, LLC | $102.43 | 2022-2025 | Thinprep 2000 Processor, Acessa Provu System |
| Astellas Pharma US INC | $102.19 | 2022-2023 | Veozah |
| Sage Therapeutics, LLC | $76.93 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $49.42 | 2021-2023 | Orilissa, Lo Loestrin Fe |
| Coopersurgical, INC. | $39.75 | 2023-2025 | Summit Doppler, Paragard T 380a |
| Myovant Sciences INC. | $37.68 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.97 | 2025 | |
| Supernus Pharmaceuticals, INC. | $25.00 | 2025 | Qelbree |
| Sumitomo Pharma America, INC. | $21.83 | 2023 | Myfembree |
| Lilly USA, LLC | $20.12 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $18.70 | 2025 | Wegovy |
| Coloplast Corp | $18.61 | 2024 | |
| Ibsa Pharma INC. | $16.61 | 2023 | Tirosint, Licart |
| Pfizer INC. | $13.55 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Van Haastert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.